CC
EDIT icon

Corton Capital’s Editas Medicine EDIT Stock Holding History

Corton Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,832
Closed -$117K – 574
2024
Q1 		$117K Sell
15,832
-5,654
-26% -$47K 0.04% 469
2023
Q4 		$218K Sell
21,486
-7,879
-27% -$69.2K 0.07% 434
2023
Q3 		$229K Buy
29,365
+15,590
+113% +$134K 0.12% 275
2023
Q2 		$113K Buy
+13,775
New +$120K 0.05% 393
2022
Q4 		– Sell
-10,933
Closed -$134K – 330
2022
Q3 		$134K Sell
10,933
-3,585
-25% -$55.9K 0.16% 216
2022
Q2 		$172K Buy
14,518
+2,901
+25% +$38.9K 0.16% 242
2022
Q1 		$221K Buy
+11,617
New +$216K 0.1% 333

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Corton Capital's EDIT Position: Q2 2024 in Review

Corton Capital sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 15,832 shares — an estimated $117K sold.

Corton Capital first reported a position in EDIT in Q1 2022 and held it in 7 quarters. The position peaked at $229K in Q3 2023. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Corton Capital reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Corton Capital sold 15,832 Editas Medicine shares in Q2 2024, an estimated $117K.
  • Corton Capital first reported a position in Editas Medicine in Q1 2022 and held it in 7 quarters.
  • Corton Capital's Editas Medicine position peaked at $229K in Q3 2023.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Corton Capital's 13F filing for Q2 2024, filed 14 Aug 2024.